<?xml version="1.0" encoding="UTF-8"?>
<p>The acute oral toxicity study was assessed on the animal model by using different concentrations and observed for any kind of toxic/adverse effects. Eczegone was orally administered to the experimental animals with various dosages (5, 50, 300, 2000 and 5000 mg/kg body weight) for 2 weeks at different intervals. The results obtained from acute oral toxicity revealed that Eczegone did not show any toxicity signs such as irritation of skin, eyes, mucus membrane, behavior pattern, tremors, salivation, diarrhea and coma or mortality at maximum given dose level of 5000 mg/kg body weight at different intervals of the up to the 2 weeks (
 <xref rid="table3-1559325820956798" ref-type="table">Table 3</xref>). Taken together, 
 <italic>in vitro</italic> and 
 <italic>in vivo</italic> study confirmed that Eczegone had no toxic effect and can be used for the management of Eczema.
</p>
